SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Annual Wellness Visit, Subsequent — Edward W. Brooke

PatientEdward W. Brooke
Date of birth1942-10-26
IdentifiersMRN HR-ML014-SYN; SSN (made up) 000-14-5063
Document date2026-10-13
AuthorHoward Bellamy, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Subsequent annual wellness visit; no new complaints. [S]

History of Present Illness

Mr. Brooke is an 83-year-old man with right breast cancer, stage IIA and hormone receptor-positive, treated by bilateral mastectomy and right axillary dissection about a year ago, who has taken tamoxifen 20 mg daily for eleven and a half months. He returns for his subsequent annual wellness visit, two months after his survivorship visit, and completed the health risk assessment beforehand. He has missed no tamoxifen doses. Hot flashes are mild and occur two or three times a week; libido is lower but he is not troubled by it. He has had no leg swelling or pain, chest pain, breathlessness, or change in vision. He has no new lump, skin change, or swelling on either side of the chest or in either armpit, and no bone pain, cough, or weight loss. He walks most days and keeps a busy schedule of writing and speaking, including talking to men about breast cancer. He has had no falls, emergency visits, or hospital stays since his operation. [S]

ElementDetail
VisitSubsequent annual wellness visit
Safety eventsNo falls, emergency visits, or hospital stays since his operation
MedicinesTamoxifen 20 mg daily; cholecalciferol 1000 units daily; no other prescription or over-the-counter medicines
Active conditionsRight breast cancer, stage IIA, on adjuvant tamoxifen, no evidence of recurrence; low bone mass at the femoral neck
Functional statusIndependent in all activities and instrumental activities of daily living

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood
PsychosocialBusy with writing, board work, and speaking; close family and friends; no loneliness or low mood
TobaccoNever used tobacco
Alcohol and drugsDoes not drink alcohol (AUDIT-C 0); no other drug use
Physical activityWalks 30 to 40 minutes most days and does light weights twice a week
NutritionRegular balanced meals; dairy twice a day for calcium
SleepSeven hours a night; hot flashes wake him about once a week
Activities of daily livingIndependent
Instrumental activities of daily livingIndependent; manages his own medicines with a weekly pill organizer; drives
Home safetySmoke detectors working; handrails on the stairs; good lighting
FallsNo falls this year; no fear of falling
Hearing and visionNo hearing concern; wears reading glasses; eye examination eight months ago
MemoryNo concerns
PainNone

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable; no fatigue, fever, or night sweats
EyesNegativeNo change in vision on tamoxifen
Ears, nose, mouth, and throatNegativeNo hearing loss or mouth problems
CardiovascularNegativeNo chest pain, palpitations, or leg swelling or pain
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo change in bowel habit or bleeding
GenitourinaryPositiveLower libido on tamoxifen, not bothersome; no urinary symptoms or blood in the urine
MusculoskeletalNegativeNo bone or joint pain; full shoulder movement
IntegumentaryNegativeNo new lump or skin change on the chest wall; no new skin lesions
NeurologicalNegativeNo headache, weakness, or numbness
PsychiatricNegativeMood good; PHQ-2 score 0
EndocrinePositiveMild hot flashes two or three times a week on tamoxifen
Hematologic and lymphaticNegativeNo arm swelling, easy bruising, or enlarged glands

13 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Tamoxifen 20 mg oral tablet, one tablet by mouth once daily (adjuvant endocrine therapy, planned for at least five years)One tablet once dailyOral route2025-10-28activeS
Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route2026-02-10activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-13Body height183cmS
2026-10-13Body weight82.4kgS
2026-10-13Body mass index (BMI) [Ratio]24.6kg/m2S
2026-10-13Systolic blood pressure130mm[Hg]S
2026-10-13Diastolic blood pressure74mm[Hg]S
2026-10-13Heart rate68/minS
2026-10-13Respiratory rate14/minS
2026-10-13Body temperature36.6CelS
2026-10-13Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-13Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-13Total score [Mini-Cog]5{score}S
2026-10-13Total score [AUDIT-C]0{score}S
2026-10-13Cholesterol [Mass/volume] in Serum or Plasma176mg/dL<=200 mg/dLNormalS
2026-10-13Cholesterol in HDL [Mass/volume] in Serum or Plasma54mg/dL>=40 mg/dLNormalS
2026-10-13Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation104mg/dL<=129 mg/dLNormalS
2026-10-13Triglyceride [Mass/volume] in Serum or Plasma92mg/dL<=149 mg/dLNormalS

Physical Exam

Vital signs recorded on 2026-10-13; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell, alert, and upright; weight 82.4 kg, BMI 24.6
EyesPupils equal and reactive; near vision 20/30 with reading glasses
EarsCanals clear; whispered-voice test passed in both ears
NeckNo thyroid enlargement; no cervical or supraclavicular nodes
Chest wallHealed transverse mastectomy scars on both sides; no nodule, thickening, or skin change on either side
Lymph nodesNo axillary nodes on either side; right axillary scar healed
CardiovascularRegular rhythm at 68 per minute; no murmur; no calf tenderness or swelling; arm circumferences equal
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; liver not enlarged
MusculoskeletalNo spinal tenderness; Timed Up and Go 10 seconds; rises from a chair without using his arms
NeurologicalAlert and oriented; gait steady; Mini-Cog 5 of 5
PsychiatricEuthymic and engaged; judgment and insight intact
SkinNo suspicious lesions

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the right male breast, central (retroareolar) portion, stage IIA (pT1c pN1a M0), grade 2, ER positive, PR positive, HER2 negative; treated by bilateral mastectomy and right axillary lymph node dissection; on adjuvant tamoxifen; synthetic modern detail linked to his publicly disclosed breast canceractiveconfirmed C50.121S — Synthetic tumor size, grade, receptor status, and stage; the diagnosis, the right side, the operation, and the spread to lymph nodes are from his public account (D).
Estrogen receptor-positive status of the breast canceractiveconfirmed Z17.0S — Synthetic receptor result; his tumor biology was not made public.
Long-term use of tamoxifen, with safety monitoring (venous thromboembolism, mood, hot flashes, sexual side effects, adherence) and bone health reviewactiveconfirmed Z79.810S — Synthetic adjuvant therapy in the modern episode.
Absence of both breasts after bilateral mastectomyactiveconfirmed Z90.13S — The double mastectomy is reported publicly (D); the coding is synthetic.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, this seasonCompleted todayHigh-dose vaccine given today
Pneumococcal vaccineCompleted todayPCV20 given today; no earlier pneumococcal vaccine on record; no further doses needed
Recombinant zoster vaccineCompleted todayDose 1 given today; dose 2 due in two to six months
RSV vaccineDueA single dose is recommended at 75 and older; he will get it at the pharmacy with his COVID-19 dose
COVID-19 vaccine, this seasonDueRecommended at his age; at the pharmacy next week
Tetanus, diphtheria, and pertussis boosterUp to dateTdap eight years ago; next dose due in two years
Colorectal cancer screeningNot indicatedScreening from 76 to 85 is selective; discussed, and not recommended for him now, given his age and his current cancer care
Prostate cancer screeningNot indicatedPSA screening is not recommended at 70 and older; his germline panel showed no BRCA2 or other variant that would change this
Breast imagingNot indicatedAfter bilateral mastectomy there is no breast to image; surveillance is by examination of both sides of the chest wall
Bone densityUp to dateDXA eight months ago: femoral neck T-score -1.2, spine -0.4; vitamin D now 36 ng/mL; repeat in two years
Cholesterol and statin decisionCompleted todayTotal cholesterol 176, HDL 54, LDL 104 mg/dL; no diabetes or smoking. Risk calculators are not validated beyond 79, and evidence for starting a statin for primary prevention after 75 is limited; not started after discussion; review yearly
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNever used tobacco
Hepatitis C and HIV screeningNot indicatedOutside the recommended age ranges and no risk factors
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 0
Cognitive assessmentCompleted todayMini-Cog 5 of 5
Falls preventionCompleted todayTimed Up and Go 10 seconds; no falls; walking and light weights continue
HearingCompleted todayWhispered-voice test passed in both ears
Eye examinationUp to dateEight months ago; tamoxifen can rarely cause cataract or retinal changes, so he will report any change in vision

Immunizations given today: High-dose influenza vaccine, 2026-2027 season; Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]

Guideline basis: CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Survivorship visit in two months. Second zoster dose in two to six months. COVID-19 and RSV vaccines at the pharmacy. Next annual wellness visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying active in his work, being told plainly about his health, and making his own decisions. He chose not to record specific treatment preferences today. The plan will be revisited yearly and with any change in his health. [S]